One tumour cells use for immune surveillance evasion is the upregulation of immune checkpoint expression, such as that of programmed death-ligand 1 (PD-L1), which attenuates T cell activation through the counterpart receptor programmed cell death protein 1 (PD-1) expressed on the surface of T cells. Here, CD274 is linked to neoplasm.